Fresenius Medical FMS Stanford Research Sell » Hold DaVita DVA Stanford Research Sell » Hold SYMYX Tech SMMX Nollenberger Capital Neutral » Buy Temple-Inland TIN Lehman Brothers Equal-weight » Overweight Orexigen Therapeutics OREX JMP Securities Mkt Outperform » Strong Buy Kaiser Alum KALU Bear Stearns Peer Perform » Outperform Green Mtn Coffee GMCR Piper Jaffray Market Perform » Outperform Kinross Gold KGC RBC Capital Mkts Sector Perform » Outperform General Motors GM Banc of America Sec Sell » Neutral Charles River CRL UBS Neutral » Buy Central European Dist CEDC Broadpoint Capital Neutral » Buy
DOWNGRADES
Cree CREE Canaccord Adams Hold » Sell Gamestop GME Citigroup Buy » Hold Petrobras Brasileiro PBR Bear Stearns Outperform » Peer Perform Comp Vale Do Rio RIO JP Morgan Overweight » Neutral Pepsi Bottling PBG Stifel Nicolaus Buy » Hold American Financial Realty Trust AFR Stifel Nicolaus Hold » Sell Ultimate Software ULTI Ferris Baker Watts Buy » Neutral Capella Education CPLA BMO Capital Markets Outperform » Market Perform Ceragon CRNT Collins Stewart Buy » Underperform Dreamworks Animation DWA Pali Research Buy » Neutral Toronto-Dominion Bank TD CIBC Wrld Mkts Sector Outperform » Sector Perform Molex MOLX Banc of America Sec Buy » Neutral Covance CVD Bear Stearns Outperform » Peer Perform Navteq NVT Banc of America Sec Buy » Neutral Parker-Hannifin PH UBS Neutral » Sell
MOST NOTEWORTHY: General Motors, Green Mountain Coffee, Orexigen and Norsk Hydro were today's noteworthy upgrades:
Banc of America upgraded shares of General Motors Corporation (NYSE: GM) to Neutral from Sell as they believe the agreement with the United Auto Workers union offsets a worsening outlook for sales.
Piper Jaffray upgraded shares of Green Mountain Coffee Roasters (NASDAQ: GMCR) to Outperform from Market Perform after a meeting with management as they believe shares offer a compelling buying opportunity at current levels based on their 2009 estimates.
JMP Securities upgraded shares of Orexigen Therapeutics (NASDAQ: OREX) to Strong Buy from Market Outperform as they believe the company's lead product candidates, Empatic and Contrave, could become front-line therapies for obesity due to improved durability of efficacy, increased safety and tolerability, and lack of addiction.
Norsk Hydro (NYSE: NHY) was upgraded to Buy from Hold at Citigroup. The firm sees upside in the stock from the volume growth and further improvements in downstream operations.
OTHER UPGRADES:
Lehman upgraded Temple Inland (NYSE TIN) to Overweight from Equal Weight.
Ciena Corporation (NASDAQ: CIEN) was upgraded to Buy from Neutral at Merrill Lynch.
HSBC upgraded ENI SpA (NYSE: E) to Overweight from Neutral.
Nollenberger raised shares of Symyx Technologies (NASDAQ: SMMX) to Buy from Neutral.
I’m one of those strange people who gets excited by big one day market declines. To me, it’s a stock clearance sale.
I have been busy today buying stocks. I added Mothers Work (MWRK) and I accumulated shares of an actual Graham net-net for the Fat Pitch Financials Port. I also picked up shares of an odd [...]